Understanding EU Plant Protection Product (PPP) Registration: Key Insights from Article 33

At Battelle, operational excellence is more than a goal- it's a shared responsibility across the U.S. Department of Energy (DOE) National Laboratories. Ed Anderson’s leadership at LANL reflects Battelle’s people-first approach to safety, trust, and mission execution.

The future of pharmaceutical manufacturing is agile. As demand for personalized therapies, rapid response, and resilient supply chains grows, the industry is shifting from traditional, rigid production to flexible, adaptive platforms. Agile manufacturing enables custom medications, on-demand therapies, and smarter, localized drug production.

Effective PFAS testing begins with a plan. Ask these key questions before analysis to prevent wasted time and maximize resources.

Learn how Battelle Solver Bevin Luna's behind the scenes work on health and safety ensures that scientific exploration thrives in Battelle's Arctic Research Operations.

As demand grows for personalized therapies, faster development timelines and more resilient supply chains, manufacturers are under pressure to rethink how drugs are made and embrace a more agile approach to production.